Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer
2021-06-09 13:38
Innoforce Pharmaceuticals to Participate in BIO International Digital Convention
2021-06-08 19:00
TargEDys announces the publication of the first double-blind, randomized, placebo-controlled clinical trial showing Hafnia alvei's efficacy at an unprecedented level in weight loss and satiety
2021-06-08 16:53
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL
2021-06-08 07:30
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs
2021-06-08 07:21
Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication
2021-06-07 08:30
Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries
2021-06-07 08:00
The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial
2021-06-04 02:00
RWDC Industries Appoints New Chief Financial Officer
2021-06-03 22:00
Peking University Biologics entering into Strategic Cooperation Agreement with Norwich Investment Limited
2021-06-03 16:29
Cell Care Joins the Generate Life Sciences Family to Create a Global Platform
2021-06-03 06:00
Nanoform raises its mid-term business targets for 2025
2021-06-02 21:42
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement
2021-06-02 21:00
Portonbio announced strategic cooperation with KAEDI to accelerate the R&D and production of CAR-T drugs
2021-06-02 20:10
PharmAbcine to Present at the BIO Digital International Convention 2021
2021-06-02 20:00
Betagenon AB announces investment and collaboration with Hong Kong-based MCG Technology Group Ltd
2021-06-02 16:23
ImmVira will present the U.S. Clinical Phase I Study Results of MVR-T3011 via Intratumoral Administration at ASCO 2021
2021-06-02 16:14
Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis; Rectal Delivery of Drug to Target Site
2021-06-02 06:00
Puyi Biotechnology Completes Series B Financing
2021-06-01 22:32
GenScript ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII
2021-06-01 21:00
1
145
146
147
148
149
151